Jingxin Pharmaceutical (002020.SZ): Cariprazine Hydrochloride Capsules and Didasinin Capsules Included in the National Medical Insurance Catalog

Zhitong Finance APP News, Jingxin Pharmaceutical (002020.SZ) issued an announcement that the company's drug Cariprazine Hydrochloride Capsules (brand name "Jingyueda") passed the national medical insurance catalog negotiation, and Didasinine Capsules (brand name "Jingnuoning") successfully renewed its contract, being included in the "National Basic Medical Insurance, Maternity Insurance, and Work-Related Injury Insurance Drug Catalog (2026)". Cariprazine Hydrochloride Capsules are used for the treatment of schizophrenia in adults. Didasinine Capsules are used for short-term treatment of insomnia patients.